biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > safe to say this

<< Previous

Bullboard Posts

Next >>

Comment by regardlesson Jan 19, 2021 9:07pm

201 Views

Post# 32330618

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:safe to say this

I think charts for our the window on a stock like this.

it's propelled by sentiment amd news which may or may not equal deals and partnerships that directly generate a monetary value for
the science

i feel charts are meaningless here no offense but a chart can't predict a partnership potential deal that shoots this up 200%
nothing can

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023